✦ LIBER ✦

793 PUBLICATION Salvage therapy with bevacizumab, capecitabin, and mitomycin C (BECAM) for patients with metastatic colorectal or gastric cancer refractory to 5-fluorouracil, oxaliplatin, irinotecan, and cetuximab

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine and mitomycin C as third-li

✍ Chong, G; Dickson, J L B; Cunningham, D; Norman, A R; Rao, S; Hill, M E; Price, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

276 Promising activity with capecitabine

✍ J.L.B. Dickson; S. Rao; M.E. Hill; T.J. Price; A.R. Norman; J. Oates; D. Cunning 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB